Clinical trial
Comparison of the Viveve Treatment and Cryogen-Only Treatment Versus Sham…
NCT04206085 · Viveve Inc., Industry · Completed
Key facts
| NCT number | NCT04206085 |
|---|---|
| Title | Comparison of the Viveve Treatment and Cryogen-Only Treatment Versus Sham Treatment for Stress Urinary Incontinence |
| Official title | Comparison of the Viveve Treatment and Cryogen-Only Treatment Versus Sham Treatment for Stress Urinary Incontinence |
| Lead sponsor | Viveve Inc., Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Stress Urinary Incontinence |
| Intervention type | Device |
| Interventions | Viveve - Active, Viveve - Cryogen-Alone, Viveve - Sham |
| Enrollment | 38 |
| Start date | Jan 1, 2020 |
| Primary completion | Aug 30, 2020 |
| Completion | Aug 30, 2020 |
| First posted | Dec 20, 2019 |
| Last update posted | Sep 21, 2022 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: